Authors: Grace, AA Brady, PA Shapiro, LM

Citation: Aa. Grace et al., Risk management in hypertrophic cardiomyopathy, LANCET, 357(9254), 2001, pp. 407-408

Authors: Luria, D Glikson, M Brady, PA Lexvold, NY Rasmussen, MJ Hodge, DO Chugh, SS Rea, RF Hayes, DL Hammill, SC Friedman, PA

Citation: D. Luria et al., Predictors and mode of detection of transvenous lead malfunction in implantable defibrillators, AM J CARD, 87(7), 2001, pp. 901

Authors: Gerber, TC Brady, PA Blackshear, JL

Citation: Tc. Gerber et al., Onset and termination of atrial fibrillation, HEART, 83(5), 2000, pp. 587-587

Authors: Tiede, DJ Brady, PA Garratt, KN Holmes, DR

Citation: Dj. Tiede et al., Resolution of the "no-reflow" phenomenon with intracoronary administrationof adenosine, J INTERV CA, 13(1), 2000, pp. 15-18

Authors: Garratt, KN Brady, PA Hassinger, NL Grill, DE Terzic, A Holmes, DR

Citation: Kn. Garratt et al., Sulfonylurea drugs increase early mortality in patients with diabetes mellitus after direct angioplasty for acute myocardial infarction, J AM COL C, 33(1), 1999, pp. 119-124

Authors: Gunn, AG Brady, PA Migenes, V Spencer, RE Doyle, JG

Citation: Ag. Gunn et al., Eclipsing behaviour of the radio emission in the Algol system V505 Sagittarii, M NOT R AST, 304(3), 1999, pp. 611-621